Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Stock Price

SHSE:688336 Community·CN¥39.3b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

688336 Share Price Performance

CN¥63.66

41.30 (184.70%)

CN¥63.66

41.30 (184.70%)

CN¥63.66

Sun, 7 Dec 25

Share Pricen/a

688336 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with solid track record.

2 Risks

3 Rewards

View Full Analysis

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 1.41
: 75.79%
: 63.52%
: 0%

View Full Analysis

About 688336

Founded: 2002
Employees: 1023
CEO: Yanli Liu
WebsiteView website: www.3s-guojian.com

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include YISAIPU, a tumor necrosis factor inhibitor type II-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Septin, an injection for anti-human epidermal growth factor receptor-2 treatment; and Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation. The company was founded in 2002 and is based in Shanghai, China.